Doctor Yuji Nishimoto
Toyonaka Municipal Hospital, Toyonaka (Japan)
Membership:
ESC Professional Member
Biography
After graduating from Osaka University in 2010, I spent 2 years as a resident of internal medicine at Toyonaka Municipal Hospital, and after 2012, I spent 4 years as a fellowship of cardiovascular medicine at Osaka Police Hospital, and 3 years as a fellowship of cardiovascular medicine at Amagasaki General Medical Center (AGMC). From 2019, I became a chief physician of cardiovascular medicine at AGMC. I am an interventionist of cardiology.
My principal research interests lie in the field of thrombosis including coronary artery, peripheral artery, and vein.
As one of the members of the COMMAND VTE Registry, I have been engaged in analyzing epidemiological data especially focusing on the management of venous thromboembolisms. My academic performance is exceptional with experience of 26 original manuscripts (10 as a first author) and 8 case reports (6 as a first author) with several times experience of English oral presentation at international
Contributor content
Presentation
Net clinical benefit of 18-month over 6-month rivaroxaban in patients with cancer and acute low-risk pulmonary embolism: Insight from the ONCO PE trial
Presentation
Application of DOAC Score for the risk-stratification of major bleeding in patients with venous thromboembolism on direct oral anticoagulants: insight from the COMMAND VTE Registry-2
Presentation
Procedural volume and outcomes in patients with cardiogenic shock who received Impella: insight from the J-PVAD Registry
Presentation
Effectiveness of an Impella versus intra-aortic balloon pump in patients who received extracorporeal membrane oxygenation: a nationwide inpatient database study
Presentation
External validation of PE-SARD bleeding score for early major bleeding in patients with acute pulmonary embolism: Insight from the COMMAND VTE Registry-2
Presentation
Trends in mechanical circulatory support use and outcomes of patients with cardiogenic shock in Japan, 2010-2020: a nationwide inpatient database study
Presentation
Risk factors of recurrence in patients with cancer-associated venous thromboembolism: from the COMMAND VTE Registry
Presentation
Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolisms: from the COMMAND VTE Registry
Presentation
Risk factors for major bleeding during prolonged anticoagulation therapy in cancer-associated venous thromboembolisms: From the COMMAND VTE Registry
Presentation
